Haleon plc (HLN)
USD 9.71
(-2.02%)
USD 9.71
(-2.02%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.96 Billion GBP | 5.85% |
| 2022 | 6.57 Billion GBP | 10.54% |
| 2021 | 5.95 Billion GBP | 0.68% |
| 2020 | 5.91 Billion GBP | 23.07% |
| 2019 | 4.8 Billion GBP | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.83 Billion GBP | 24.11% |
| 2024 Q2 | 1.71 Billion GBP | -2.29% |
| 2023 Q4 | 1.48 Billion GBP | -13.69% |
| 2023 FY | 6.96 Billion GBP | 5.85% |
| 2023 Q3 | 1.71 Billion GBP | 0.35% |
| 2023 Q2 | 1.71 Billion GBP | -7.07% |
| 2023 Q1 | 1.84 Billion GBP | -16.59% |
| 2022 Q3 | 1.81 Billion GBP | 13.83% |
| 2022 Q1 | 1.61 Billion GBP | 75.33% |
| 2022 Q4 | 2.2 Billion GBP | 21.28% |
| 2022 FY | 6.57 Billion GBP | 10.54% |
| 2022 Q2 | 1.59 Billion GBP | -0.93% |
| 2021 Q2 | 1.42 Billion GBP | 1.5% |
| 2021 Q3 | 1.55 Billion GBP | 9.42% |
| 2021 Q4 | 920 Million GBP | -40.91% |
| 2021 Q1 | 1.4 Billion GBP | 0.0% |
| 2021 FY | 5.95 Billion GBP | 0.68% |
| 2020 FY | 5.91 Billion GBP | 23.07% |
| 2019 FY | 4.8 Billion GBP | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 820.56 Million USD | -748.44% |
| Bausch Health Companies Inc. | 6.19 Billion USD | -12.327% |
| Catalent, Inc. | 953 Million USD | -630.535% |
| Emergent BioSolutions Inc. | 343.9 Million USD | -1924.426% |
| Elanco Animal Health Incorporated | 2.48 Billion USD | -180.048% |
| Perrigo Company plc | 1.68 Billion USD | -314.306% |
| Teva Pharmaceutical Industries Limited | 7.64 Billion USD | 8.946% |
| Zoetis Inc. | 5.83 Billion USD | -19.335% |